Cargando…

Cost of blood screening.

Detalles Bibliográficos
Autor principal:	Chang, O J
Formato:	Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 1998
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2640301/ https://www.ncbi.nlm.nih.gov/pubmed/9716992

Ejemplares similares

Cost-effectiveness of population-based screening for colorectal cancer
por: O'Mahony, J F
Publicado: (2013)

Cost-Effective Screening for Trichomoniasis
por: Schwebke, Jane R.
Publicado: (2002)

Cost-effectiveness of screening for hepatocellular carcinoma: putting the cart before the horse
por: Braillon, Alain
Publicado: (2012)

Screening Methods for Active Toxoplasmosis in Animal Blood Samples
por: Mohaghegh, Mohammad Ali, et al.
Publicado: (2016)

Cost-Effective Screening for Trichomoniasis—reply to Dr. Schwebke
por: Sorvillo, Frank, et al.
Publicado: (2002)

Colonoscopy colorectal cancer screening: Cost-effectiveness in Thailand
por: Joob, Beuy, et al.
Publicado: (2016)

Reply: cost-effectiveness of population-based screening for colorectal cancer
por: Sharp, L, et al.
Publicado: (2013)

PCOSt: A non-invasive and cost-effective screening tool for polycystic ovary syndrome
por: Xu, Huiyu, et al.
Publicado: (2023)

Comment on: use of blood biomarkers to screen for obstructive sleep apnea
por: Abrams, Burton
Publicado: (2018)

Genetic screening for neovascular AMD: cost effective…not so quick
por: Reichel, Elias
Publicado: (2015)

Screening for arboviruses in healthy blood donors: Experience from Karachi, Pakistan
por: Khan, Moiz Ahmed, et al.
Publicado: (2022)

Usefulness of seminested polymerase chain reaction for screening blood donors at risk for malaria in Spain.
por: Benito, A, et al.
Publicado: (2001)

Red blood cell antibody screening in pregnancy
por: Devi, Shanthala A. M., et al.
Publicado: (2011)

The Cost of Screening Blood Donations for West Nile Virus
Publicado: (2006)

Reply to: Balancing Cost and Efficiency in Screening Potential Organ Donors With Whole Body CT
por: Mensink, Jacobus W., et al.
Publicado: (2020)

Balancing Cost and Efficiency in Screening Potential Organ Donors With Whole Body CT
por: Lormans, Piet, et al.
Publicado: (2020)

Screening Blood Donors at Risk for Malaria: Reply to Hänscheid et al.
por: Benito, A., et al.
Publicado: (2002)

The cost of folinic acid.
por: Healy, J. B.
Publicado: (1990)

Cord Blood Sample Screening for Evidence of Maternal Chagas Disease
por: Montgomery, Susan P., et al.
Publicado: (2017)

Cost-Effectiveness of Blood Donation Screening for Trypanosoma cruzi in Mexico
por: Sánchez-González, Gilberto, et al.
Publicado: (2016)

Reply to: Comments on “Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modeled strategies”
por: Kregting, Lindy M., et al.
Publicado: (2022)

Comment on “Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population”
por: Ahlquist, David A
Publicado: (2017)

Storage and use of residual newborn screening dot blood samples in Italy
por: Petrini, Carlo, et al.
Publicado: (2011)

An Improved NAT Assay with Enhanced Sensitivity for HBV for Donor Blood Screening
por: Chatterjee, Kabita
Publicado: (2012)

Twizzlers as a Cost-Effective and Equivalent Alternative to the Glucola Beverage in Diabetes Screening
por: Racusin, Diana A., et al.
Publicado: (2013)

Gender-based stereotyping and cost discrepancies for razors
por: Chang, Michelle J., et al.
Publicado: (2021)

Quantifying the costs of pre‐ and postcopulatory traits for males: Evidence that costs of ejaculation are minor relative to mating effort
por: Chung, Meng‐Han Joseph, et al.
Publicado: (2021)

Polymerase Chain Reaction for Screening Blood Donors at Risk for Malaria: Safe and Useful?
por: Hänscheid, T., et al.
Publicado: (2002)

Scaling-up hepatitis C screening and treatment in Swiss outpatient psychiatric settings: A cost-effectiveness analysis
por: Girardin, François, et al.
Publicado: (2022)

Comparison of Screening Colonoscopy Rates After Positive Noninvasive Testing for Colorectal Cancer in States With and Without Cost-Sharing
por: Barthold, Douglas, et al.
Publicado: (2022)

Risk Classification-Based and Universal Screening in Management of COVID-19 Outbreak Situation: A Cost–Utility Analysis
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Integration of quality improvement and cost-efficiency through industrial improvement techniques
por: Vink, Jasper P, et al.
Publicado: (2016)

Estimating costs of environmental disease.
por: Rigas, Marc L
Publicado: (2003)

Human life cost in anaesthesiology cost-benefit decisions
por: Naftalovich, Rotem, et al.
Publicado: (2021)

Cervical cancer screening.
por: van Oortmarrsen, G. J., et al.
Publicado: (1990)

Costs of sleep apnoea treatment can be reduced
por: Farré, R, et al.
Publicado: (2021)

Screening and the costs of treating colorectal cancer.
por: Whynes, D. K., et al.
Publicado: (1993)

Out-of-Pocket Costs for Colonoscopy After Noninvasive Colorectal Cancer Screening Among US Adults With Commercial and Medicare Insurance
por: Fendrick, A. Mark, et al.
Publicado: (2021)

Cost-Effectiveness of Alternative Blood-Screening Strategies for West Nile Virus in the United States
por: Korves, Caroline T, et al.
Publicado: (2006)

An expanded role for blood donor emerging pathogens surveillance
por: O’Brien, Sheila F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_meb40u8n5udi7bf8ejjvgovt0o